posaconazole
An N-arylpiperazine that consists of piperazine carrying two 4-substituted phenyl groups at positions 1 and 4. A triazole antifungal drug.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
triazole antifungalARO:3007499
-
CHEBI:26912 -
CHEBI:35618 -
CHEBI:35727 -
CHEBI:37143 -
CHEBI:46848 - conazole antifungal drug
CHEBI:87071 - triazole antifungal drug
CHEBI:87101 - triazole antifungal
ARO:3007499
Chemical structure
| Molecular formula | C37H42F2N8O4 |
|---|---|
| Charge | 0 |
| Average mass | 700.791 Da |
| Monoisotopic mass | 700.32971 Da |
| Source | ChEBI |
| InChIKey | RAGOYPUPXAKGKH-XAKZXMRKSA-N |
CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O
InChI=1S/C37H42F2N8O4/c1-3-35(26(2)48)47-36(49)46(25-42-47)31-7-5-29(6-8-31)43-14-16-44(17-15-43)30-9-11-32(12-10-30)50-20-27-19-37(51-21-27,22-45-24-40-23-41-45)33-13-4-28(38)18-34(33)39/h4-13,18,23-27,35,48H,3,14-17,19-22H2,1-2H3/t26-,27+,35-,37-/m0/s1
Also called
- Noxafil
- 2,5-anhydro-1,3,4-trideoxy-2-(2,4-difluorophenyl)-4-({4-[4-(4-{1-[(2S,3S)-2-hydroxypentan-3-yl]-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl}phenyl)piperazin-1-yl]phenoxy}methyl)-1-(1H-1,2,4-triazol-1-yl)-D-threo-pentitol
- SCH56592
- Sch 56592
- Schering 56592
Cross-references
- posaconazole
ARO:3007513 - cas:171228-49-2
- reaxys:8379448
- chembl:CHEMBL1397
- pubchem.compound:468595
Drug registries
Patents and articles
Activity roles
- antifungal agent
CHEBI:35718 - trypanocidal drug
CHEBI:36335 - antifungal drug
CHEBI:86327
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:3007513 |
posaconazole | antibioticmech:aro-10b0bd302a |
2026-08-30 |
| CHEBI | CHEBI:64355 |
posaconazole | antibioticmech:chebi-5ebcb88ca0 |
2026-08-30 |
Mechanism summary
- Mode of action
- ERGOSTEROL_PATHWAY_INHIBITION host shared target
- Clinical status
- APPROVED
Resistance mechanisms
ANTIBIOTIC_TARGET_ALTERATION 20
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Aspergillus flavus Cyp51A with mutations associated with resistance to posaconazole | ARO:3009496 | — | ||
| Aspergillus flavus Cyp51c with mutations conferring resistance to posaconazole | ARO:3009492 | — | ||
| Aspergillus fumigatus Cyp51B with mutations conferring resistance to posaconazole | ARO:3009484 | — | ||
| Aspergillus fumigatus Hmg1 with mutations conferring resistance to posaconazole | ARO:3009230 | — | ||
| Aspergillus fumigatus Hmg2 with mutations conferring resistance to posaconazole | ARO:3009366 | — | ||
| Aspergillus fumigatus ase1 with mutations conferring resistance to posaconazole | ARO:3009272 | — | ||
| Aspergillus fumigatus cyp51a with mutations conferring resistance to posaconazole | ARO:3009203 | — | ||
| Aspergillus spp. Hmg1 with mutations conferring resistance to triazoles antibiotics | ARO:3007670 | — | ||
| Aspergillus spp. cyp51A with mutations conferring resistance to triazoles antibiotics | ARO:3007565 | — | ||
| Aspergillus tubingensis Cyp51a with mutations conferring resistance to posaconazole | ARO:3009510 | — | ||
| Candida albicans ERG11 lanosterol 14-alpha-demethylase with mutations conferring resistance to posaconazole | ARO:3009575 | — | ||
| Candida albicans cyp51 with mutations conferring resistance to posaconazole | ARO:3009525 | — | ||
| Candida auris Erg11 lanosterol 14-alpha-demethylase with mutations associated with resistance to posaconazole | ARO:3009220 | — | ||
| Candida glabrata ERG11 with mutations conferring resistance to posaconazole | ARO:3009398 | — | ||
| Candida parapsilosis Erg3 C-5 sterol desaturase with mutations conferring resistance to posaconazole | ARO:3009244 | — | ||
| Candida tropicalis Erg11 lanosterol 14-alpha-demethylase with mutations conferring resistance to posaconazole | ARO:3009585 | — | ||
| Cryptococcus neoformans Erg11 lanosterol 14-alpha-demethylase with mutations conferring resistance to posaconazole | ARO:3009587 | — | ||
| Nakaseomyces glabratus FKS2 beta-1,3-glucan synthase with mutations associated with resistance to posaconazole | ARO:3009619 | — | ||
| Nakaseomyces glabratus FSK1 beta-1,3-glucan synthase with mutations associated with resistance to posaconazole | ARO:3009615 | — | ||
| Saccharomyces cerevisiae ERG11 lanosterol 14-alpha-demethylase with mutations conferring resistance to posaconazole | ARO:3009590 | — |
UNKNOWN 6
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Candida albicans TAC1 with mutations conferring resistance to posaconazole | ARO:3009430 | — | ||
| HapE transformant(Isolate3-HapE(P88L)) (transformant) [Not assayed] associated with resistance to posaconazole |
— | Aspergillus fumigatus NCBITaxon:746128PHIPO:0000625 |
— | |
| cyp51A transformant(MS6-cyp51A(G54R)) (transformant) [Ectopic] associated with resistance to posaconazole |
— | Aspergillus fumigatus NCBITaxon:746128PHIPO:0000625 |
— | |
| cyp51A transformant(R7-1-cyp51A(G54W)) (transformant) [Ectopic] associated with resistance to posaconazole |
— | Aspergillus fumigatus NCBITaxon:746128PHIPO:0000625 |
— | |
| cyp51A(G54R) (amino acid mutation) [Not assayed] associated with resistance to posaconazole |
— | Aspergillus fumigatus NCBITaxon:746128PHIPO:0000625 |
— | |
| cyp51A(G54W) (amino acid mutation) [Not assayed] associated with resistance to posaconazole |
— | Aspergillus fumigatus NCBITaxon:746128PHIPO:0000625 |
— |
ANTIBIOTIC_EFFLUX 2
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Candida glabrata CDR1 with mutations conferring resistance to posaconazole | ARO:3009439 | — | ||
| Candida glabrata Yor1 with mutations conferring resistance to posaconazole | ARO:3009466 | — |
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (ARO, CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Scoped imported associations to the reported parent background: Af293 reference protein and strain TaxID are not tested-subject identities. Source alterations, phenotypes, assays and clinical activities unchanged; no exact allele or genome inferred.
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Refreshed the whole-file PHI-base review checksum after one yeast identity-scope correction; biological fields, activities and prior decisions unchanged.
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Refreshed the whole-file PHI-base review checksum after twelve reference-scope corrections; biological fields, activities and prior decisions unchanged.
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Refreshed the shared PHI-base review checksum after nine identifier-scope corrections; previous decisions, biological fields and activities unchanged.
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Refreshed the shared PHI-base review checksum after six identifier-scope corrections; previous decisions, biological fields and activities unchanged.
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Refreshed the shared PHI-base review checksum after eight subject-identity corrections; previous decisions, biological fields and activities unchanged.
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Refreshed shared PHI-base review checksum after the Darlington subject correction; prior review decisions, biological fields and activities unchanged.
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Refreshed shared PHI-base review checksum after the Nakayama reference-scope review; prior decisions, biological fields and activities unchanged.
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Refreshed shared PHI-base review checksum after the Duan reference-scope review; prior decisions, biological fields and activities unchanged.
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Refreshed shared PHI-base review checksum after the Piotrowska parent-reference review; prior decisions, biological fields and activities unchanged.
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Refreshed shared PHI-base review checksum after the Xu subject and species corrections; prior decisions, biological fields and activities unchanged.
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Refreshed shared PHI-base review checksum after the Shima parent-reference review; prior decisions, biological fields and activities unchanged.
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Refreshed shared PHI-base review checksum after the Mehrabi parent-reference review; prior decisions, biological fields and activities unchanged.
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Refreshed shared PHI-base review checksum after the Huang parent-reference review; prior decisions, biological fields and activities unchanged.
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Refreshed shared PHI-base review checksum after the HDF1 subject-reference review; prior decisions, biological fields and activities unchanged.
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Refreshed shared PHI-base review checksum after the Fouche parent-cohort review; prior decisions, biological fields and activities unchanged.
-
REVIEWED_RESISTANCE_REFERENCE_CONTEXT
Refreshed shared PHI-base review checksum after the SDH8 reference-alias correction; prior decisions, biological fields and activities unchanged.
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Refreshed the shared PHI-base review checksum after the Posteraro subject-context review; previous decisions, biological fields and activities unchanged.
-
REVIEWED_RESISTANCE_REFERENCE_CONTEXT
Refreshed the shared PHI-base review checksum after four reference-identifier scope corrections; previous decisions, biological fields and activities unchanged.
-
REVIEWED_RESISTANCE_SUBJECT_CONTEXT
Refreshed the shared PHI-base review checksum after one Neurospora subject-context correction; previous decisions, biological fields and activities unchanged.